INDIA
MONEY
TRAVELLER
LUXE
HINDI

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
Spotlight
Magazine Special Edition

home
Topic
Piramal group

Piramal Group

Piramal Group

Piramal Pharma Stock Surges 8% on Impressive Q2 Revenue Growth

BY Outlook Business Desk

Protesting Against Online Pharmacy, Chemists Observe Nationwide Shutdown Today

Piramal Pharma's Rs 1,050-Cr Rights Issue Gets Sebi's Nod

BY PTI

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

BY PTI

Piramal Realty is targeting about Rs 2,200 crore sales bookings this fiscal

Piramal Realty Eyes Rs 2,200 Crore Sales Bookings In FY'23, Up Over 40% Year-On-Year

BY Press Trust of India

Cosmea Pulls Out Of Race To Acquire Reliance Capital

Cosmea Pulls Out Of Race To Acquire Reliance Capital

BY Press Trust of India

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

BY Press Trust of India

The company had posted a net profit of Rs 799 crore for the same period last fiscal year.

Piramal Enterprises Profit Up 11% At Rs 888 Crore In December Quarter

BY PTI

Advertisement

NCLAT direction came over a batch of petitions filed by Union Bank of India on behalf of the CoC.

NCLAT Sets Aside NCLT Order To Consider 2nd Offer By DHFL's Former Promoter

BY PTI

Under Project Sangam DHFLs senior professionals will move to new corporate premises in Mumbai.

Piramal Group Integrates Over 3,000 Employees Of DHFL

BY PTI

In September 2021, Piramal Capital acquired DHFL for a total consideration of Rs 34,250 crore.

Piramal Group Plans To Move Supreme Court Challenging NCLAT Order On DHFL

BY PTI

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2024 Outlook Publishing India Pvt Ltd.

Copyright © 2024 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.